BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31279298)

  • 1. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
    Ouellette V; Côté MF; Gaudreault RC; Tajmir-Riahi HA; Bérubé G
    Eur J Med Chem; 2019 Oct; 179():660-666. PubMed ID: 31279298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New platinum(II) complexes conjugated at position 7α of 17β-acetyl-testosterone as new combi-molecules against prostate cancer: design, synthesis, structure-activity relationships and biological evaluation.
    Fortin S; Brasseur K; Morin N; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Oct; 68():433-43. PubMed ID: 23994871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic Pt(IV) Conjugate with Target Selectivity for Androgen Receptor.
    Qin X; Fang L; Zhao J; Gou S
    Inorg Chem; 2018 May; 57(9):5019-5029. PubMed ID: 29667815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and preliminary in vitro biological evaluation of 7α-testosterone-chlorambucil hybrid designed for the treatment of prostate cancer.
    Bastien D; Hanna R; Leblanc V; Asselin É; Bérubé G
    Eur J Med Chem; 2013 Jun; 64():442-7. PubMed ID: 23665800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative C
    Paquin A; Oufqir Y; Sevrioukova IF; Reyes-Moreno C; Bérubé G
    Eur J Med Chem; 2021 Aug; 220():113496. PubMed ID: 33933755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.
    Kazui Y; Fujii S; Yamada A; Ishigami-Yuasa M; Kagechika H; Tanatani A
    Bioorg Med Chem; 2018 Oct; 26(18):5118-5127. PubMed ID: 30228001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the synthesis and anticancer potential of L-tyrosine-platinum(II) hybrid molecules.
    Descôteaux C; Brasseur K; Leblanc V; Asselin E; Bérubé G
    Med Chem; 2015; 11(8):717-24. PubMed ID: 25938424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel steroidal imidazoles as dual inhibitors of AR/CYP17 for the treatment of prostate cancer.
    Hou Q; He C; Lao K; Luo G; You Q; Xiang H
    Steroids; 2019 Oct; 150():108384. PubMed ID: 30885648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New testosterone derivatives as semi-synthetic anticancer agents against prostate cancer: synthesis and preliminary biological evaluation.
    Morin N; Bruneau J; Fortin S; Brasseur K; Leblanc V; Asselin E; Berube G
    Med Chem; 2015; 11(6):531-9. PubMed ID: 25675439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
    Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
    Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
    Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
    Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico selection and cell-based characterization of selective and bioactive compounds for androgen-dependent prostate cancer cell.
    Cruz EC; Carecho AR; Saidel ME; Montanari CA; Leitão A
    Bioorg Med Chem Lett; 2017 Feb; 27(3):546-550. PubMed ID: 28011219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancer.
    Kandil S; Westwell AD; McGuigan C
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2000-4. PubMed ID: 26965862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloro-platinum(II): an endocrine-active platinum complex with a specific prostatic tumor-inhibiting activity.
    Schneider MR; Schiller CD; Humm A; Spruss T; Schönenberger H; Amselgruber W; Sinowatz F
    Prostate; 1989; 15(2):135-48. PubMed ID: 2798231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
    Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
    Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of naphthalenebenzimidizole platinum (II) complexes as potential antitumor agents.
    Liang GB; Yu YC; Wei JH; Kuang WB; Chen ZF; Zhang Y
    Eur J Med Chem; 2020 Feb; 188():112033. PubMed ID: 31923857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfolded Protein Response is Involved in Trans-Platinum (II) Complex-Induced Apoptosis in Prostate Cancer Cells via ROS Accumulation.
    Karakas D; Cevatemre B; Oral AY; Yilmaz VT; Ulukaya E
    Anticancer Agents Med Chem; 2019; 19(9):1184-1195. PubMed ID: 30963984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel C
    Vesper AR; Lacroix J; C-Gaudreault R; Tajmir-Rihai HA; Bérubé G
    Steroids; 2016 Nov; 115():98-104. PubMed ID: 27553724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Evaluation of Novel Substituted (5-methyl-1H-pyrazol-3-yl)- 1,3,4-oxadiazole as Potent Androgen Receptor Antagonist.
    Andavar S; Vaithilingam M; Selvaraj D; Kumaran AA; Devanathan K
    Anticancer Agents Med Chem; 2020; 20(1):84-93. PubMed ID: 31755396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
    Inoue K; Urushibara K; Kanai M; Yura K; Fujii S; Ishigami-Yuasa M; Hashimoto Y; Mori S; Kawachi E; Matsumura M; Hirano T; Kagechika H; Tanatani A
    Eur J Med Chem; 2015 Sep; 102():310-9. PubMed ID: 26295173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.